Literature DB >> 24974207

Family history of inflammatory bowel disease among patients with ulcerative colitis: a systematic review and meta-analysis.

Ryan E Childers1, Swathi Eluri2, Christine Vazquez3, Rayna Matsuno Weise4, Theodore M Bayless3, Susan Hutfless3.   

Abstract

BACKGROUND AND AIMS: Despite numerous shared susceptibility loci between Crohn's disease and ulcerative colitis, the prevalence of family history among ulcerative colitis patients is not well-established and considered to be less prevalent. A systemic review and meta-analysis were conducted to estimate the prevalence of family history of inflammatory bowel disease in ulcerative colitis patients, and its effect on disease outcomes.
METHODS: PubMED was searched to identify studies reporting the prevalence of family history of inflammatory bowel disease among ulcerative colitis patients. Definitions of family history, study type, and subtypes of family history prevalence were abstracted, as were disease outcomes including age at ulcerative colitis diagnosis, disease location, surgery and extraintestinal manifestations. Pooled prevalence estimates were calculated using random effects models.
RESULTS: Seventy-one studies (86,824 patients) were included. The prevalence of a family history of inflammatory bowel disease in ulcerative colitis patients was 12% (95% confidence interval [CI] 11 to 13%; range 0-39%). Family history of ulcerative colitis (9%; 22 studies) was more prevalent than Crohn's disease (2%; 18 studies). Patients younger than 18years of age at time of diagnosis had a greater family history of inflammatory bowel disease (prevalence 15%, 95% CI: 11-20%; 13 studies). There were no differences in disease location, need for surgery, or extraintestinal manifestations among those with a family history, although very few studies reported on these outcomes.
CONCLUSIONS: Overall, 12% of ulcerative colitis patients have a family history of inflammatory bowel disease, and were more likely to have a family history of ulcerative colitis than Crohn's disease. Pediatric-onset ulcerative colitis patients were more likely to have a family history of inflammatory bowel disease.
Copyright © 2014 European Crohn's and Colitis Organisation. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Family history; Inflammatory bowel disease; Meta-analysis; Prevalence; Ulcerative colitis

Mesh:

Year:  2014        PMID: 24974207     DOI: 10.1016/j.crohns.2014.05.008

Source DB:  PubMed          Journal:  J Crohns Colitis        ISSN: 1873-9946            Impact factor:   9.071


  14 in total

1.  Fasting-Mimicking Diet Modulates Microbiota and Promotes Intestinal Regeneration to Reduce Inflammatory Bowel Disease Pathology.

Authors:  Priya Rangan; Inyoung Choi; Min Wei; Gerardo Navarrete; Esra Guen; Sebastian Brandhorst; Nobel Enyati; Gab Pasia; Daral Maesincee; Vanessa Ocon; Maya Abdulridha; Valter D Longo
Journal:  Cell Rep       Date:  2019-03-05       Impact factor: 9.423

2.  Differences in Clinical Course, Genetics, and the Microbiome Between Familial and Sporadic Inflammatory Bowel Diseases.

Authors:  Nienke Z Borren; Grace Conway; John J Garber; Hamed Khalili; Shrish Budree; Himel Mallick; Vijay Yajnik; Ramnik J Xavier; Ashwin N Ananthakrishnan
Journal:  J Crohns Colitis       Date:  2018-04-27       Impact factor: 9.071

Review 3.  Huangqin-Tang and Ingredients in Modulating the Pathogenesis of Ulcerative Colitis.

Authors:  Chunyan Wang; Xudong Tang; Li Zhang
Journal:  Evid Based Complement Alternat Med       Date:  2017-06-12       Impact factor: 2.629

4.  Association between Passive Smoking from the Mother and Pediatric Crohn's Disease: A Japanese Multicenter Study.

Authors:  Koji Uchiyama; Yasuo Haruyama; Hiromi Shiraishi; Kiyohiko Katahira; Daiki Abukawa; Takashi Ishige; Hitoshi Tajiri; Keiichi Uchida; Kan Uchiyama; Masakazu Washio; Erika Kobashi; Atsuko Maekawa; Kazushi Okamoto; Toshimi Sairenchi; Yuka Imamura; Shuji Ohhira; Akira Hata; Gen Kobashi
Journal:  Int J Environ Res Public Health       Date:  2020-04-23       Impact factor: 3.390

5.  Association of rosacea with inflammatory bowel disease: A MOOSE-compliant meta-analysis.

Authors:  Fang-Ying Wang; Ching-Chi Chi
Journal:  Medicine (Baltimore)       Date:  2019-10       Impact factor: 1.817

6.  Identification of genes and functional coexpression modules closely related to ulcerative colitis by gene datasets analysis.

Authors:  Jie Zhu; Zheng Wang; Fengzhe Chen; Changhong Liu
Journal:  PeerJ       Date:  2019-11-13       Impact factor: 2.984

7.  Real-world disease activity and sociodemographic, clinical and treatment characteristics of moderate-to-severe inflammatory bowel disease in Brazil.

Authors:  Cyrla Zaltman; Rogério Serafim Parra; Ligia Yukie Sassaki; Genoile Oliveira Santana; Maria de Lourdes Abreu Ferrari; Sender J Miszputen; Heda M B S Amarante; Roberto Luiz Kaiser Junior; Cristina Flores; Wilson R Catapani; José Miguel Luz Parente; Mauro Bafutto; Odery Ramos; Carolina D Gonçalves; Isabella Miranda Guimaraes; Jose J R da Rocha; Marley R Feitosa; Omar Feres; Rogerio Saad-Hossne; Francisco Guilherme Cancela Penna; Pedro Ferrari Sales Cunha; Tarcia Nf Gomes; Rodrigo Bremer Nones; Mikaell Alexandre Gouvea Faria; Mírian Perpétua Palha Dias Parente; António S Scotton; Rosana Fusaro Caratin; Juliana Senra; Júlio Maria Chebli
Journal:  World J Gastroenterol       Date:  2021-01-14       Impact factor: 5.742

8.  Colitis and Crohn's Foundation (India): a first nationwide inflammatory bowel disease registry.

Authors:  Ajit Sood; Kirandeep Kaur; Ramit Mahajan; Vandana Midha; Arshdeep Singh; Sarit Sharma; Amarender Singh Puri; Bhabhadev Goswami; Devendra Desai; C Ganesh Pai; Kiran Peddi; Mathew Philip; Rakesh Kochhar; Sandeep Nijhawan; Shobna Bhatia; N Sridhara Rao
Journal:  Intest Res       Date:  2020-07-13

Review 9.  Genetics and Therapeutics in Pediatric Ulcerative Colitis: the Past, Present and Future.

Authors:  Luis Sifuentes-Dominguez; Ashish S Patel
Journal:  F1000Res       Date:  2016-02-29

10.  Familial aggregation of inflammatory bowel disease in India: prevalence, risks and impact on disease behavior.

Authors:  Rupa Banerjee; Partha Pal; Susan Hutfless; B Girish Ganesh; D Nageshwar Reddy
Journal:  Intest Res       Date:  2019-08-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.